Home/Filings/4/0001209191-22-018885
4//SEC Filing

Morris Carl Ashley 4

Accession 0001209191-22-018885

CIK 0001707502other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 5:14 PM ET

Size

6.8 KB

Accession

0001209191-22-018885

Insider Transaction Report

Form 4
Period: 2022-03-14
Morris Carl Ashley
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2022-03-14$1.10/sh11,396$12,536255,209 total
  • Sale

    Common Stock

    2022-03-14$1.10/sh11,269$12,396266,605 total
Footnotes (2)
  • [F1]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
  • [F2]Includes 2,272 shares acquired by Mr. Morris under the Solid Biosciences Employee Stock Purchase Plan on November 30, 2021.

Issuer

Solid Biosciences Inc.

CIK 0001707502

Entity typeother

Related Parties

1
  • filerCIK 0001727571

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:14 PM ET
Size
6.8 KB